KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
28 Novembre 2023 - 2:00PM
Business Wire
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or
the "Company"), a leading medical technology company focused on
the development, manufacturing, and commercialization of innovative
and easy-to-use specialty subcutaneous infusion solutions that
improve quality of life for patients, today announced it will host
an investor day at the Mahwah, NJ headquarters on Tuesday, December
5, 2023, from 10:00 a.m. to 12:00 p.m. Eastern Time. The event will
include presentations by members of management and an expert
immunologist. The presentations will cover KORU Medical’s key
markets, growth strategy, product portfolio, and operational and
financial performance.
In-person attendance for the event requires advanced
registration. Please email Hannah Jeffrey at hannah@gilmartinir.com
by December 1, 2023, to register.
For those who cannot attend in-person, a live and archived
webcast of the presentations will be available on the News/Events
page of the Investors section of KORU Medical System's website at
www.korumedical.com.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous drug delivery systems that
improve quality of life for patients around the world. The FREEDOM™
Infusion System currently includes the FREEDOM60® and FreedomEdge®
Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo
Subcutaneous Safety Needle Sets™. The FREEDOM™ Infusion System is
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128260743/en/
Investor Contact: Greg Chodaczek 347-620-7010
investors@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
KORU Medical Systems (NASDAQ:KRMD)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025